目的 研究盐酸川芎嗪(TMPH)经大鼠鼻腔给药后的脑内药动学特性。方法 采用脑微透析取样技术,以清醒自由活动大鼠为实验模型,连续收集盐酸川芎嗪鼻腔和静脉注射给药后大鼠脑内纹状体透析液,HPLC测定其浓度,并经回收率校正后,以WinNonlin4.0.1药动学软件处理,计算药动学参数并进行统计学分析。结果 TMPH鼻腔给药5min后脑纹状体中的药物浓度为(1.43±0.29)mg·L^-1,而静脉注射后在相同时间点入脑不显著。鼻腔给药的ρmax低于静脉注射,分别为(3.43±0.46)和(4.67±0.76)mg·L^-1,但二者的tmax,AUC0-∞,MRT,CLs近似,无显著性差异(P〉0.05).结论 TMPH鼻腔给药后可迅速吸收入脑,且吸收量与静脉注射近似,因此有望成为一种新的给药途径。
OBJECTIVE To investigate the brain pharmacokinetics of tetramethylpyrazine hydrochloride(TMPH)after intranasal administration in rats. METHODS Striatum dialysate samples were continuously collected by brain mierodialysis technique in awake freely-moving rats. The concentration of TMPlt in dialysate samples were measured by HPLC. The pharmaeokinetie parameters were calculated by WinNonlin4. 0. 1 and statistically analyzed. RESULTS The TMPH concentration in striatum five minutes after intranasal administration was ( 1.43 ± 0. 29) mg·L^-1, while much lower concentration was found atier intravenous injection administration. The value of p after intranasal administration was (3.43 ± 0. 46) mg · L^-1, lower than the value of intravenous injection, (4.67 ±0. 76) mg ·L^-1. However, there was no signitieant rill'terence among the values of tmax AUC0-∞, AUC0-∞ , MRT and CLs of the two administration routes( P 〉0.05 ). CONCLUSION TMPH coohl be absorbed into the brain promptly after in administration and the ahsorption amount was similar to iv administration. Therefore, it could be a promising alternative delivery tot TMPH in the future.